{"id":"https://openalex.org/W1997785301","doi":"https://doi.org/10.1177/089198879100400408","title":"Acute Extrapyramidal Syndromes in Neuroleptic-Treated Elders: A Pilot Study","display_name":"Acute Extrapyramidal Syndromes in Neuroleptic-Treated Elders: A Pilot Study","publication_year":1991,"publication_date":"1991-10-01","ids":{"openalex":"https://openalex.org/W1997785301","doi":"https://doi.org/10.1177/089198879100400408","mag":"1997785301","pmid":"https://pubmed.ncbi.nlm.nih.gov/1686396"},"language":"en","primary_location":{"id":"doi:10.1177/089198879100400408","doi":"https://doi.org/10.1177/089198879100400408","is_oa":false,"landing_page_url":"https://doi.org/10.1177/089198879100400408","pdf_url":null,"source":{"id":"https://openalex.org/S182765863","display_name":"Journal of Geriatric Psychiatry and Neurology","issn_l":"0891-9887","issn":["0891-9887","1552-5708"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Geriatric Psychiatry and Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021943893","display_name":"Linda K. Ganzini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I2803065977","display_name":"Portland VA Medical Center","ror":"https://ror.org/02v3txv81","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2803065977","https://openalex.org/I4210144745"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda Ganzini","raw_affiliation_strings":["Psychiatry Service, Portland Veterans Affairs Medical Center, and the Department of Psychiatry, Oregon Health Sciences University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Service, Portland Veterans Affairs Medical Center, and the Department of Psychiatry, Oregon Health Sciences University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I2803065977"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ronald Heintz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I2803065977","display_name":"Portland VA Medical Center","ror":"https://ror.org/02v3txv81","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2803065977","https://openalex.org/I4210144745"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald Heintz","raw_affiliation_strings":["Psychiatry Service, Portland Veterans Affairs Medical Center, and the Department of Psychiatry, Oregon Health Sciences University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Service, Portland Veterans Affairs Medical Center, and the Department of Psychiatry, Oregon Health Sciences University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I2803065977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108432663","display_name":"William F. Hoffman","orcid":"https://orcid.org/0009-0003-4062-3093","observed_orcids":["https://orcid.org/0009-0003-4062-3093"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I2803065977","display_name":"Portland VA Medical Center","ror":"https://ror.org/02v3txv81","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2803065977","https://openalex.org/I4210144745"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William F. Hoffman","raw_affiliation_strings":["Psychiatry Service, Portland Veterans Affairs Medical Center, and the Department of Psychiatry, Oregon Health Sciences University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Service, Portland Veterans Affairs Medical Center, and the Department of Psychiatry, Oregon Health Sciences University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I2803065977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002100169","display_name":"George A. Keepers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I2803065977","display_name":"Portland VA Medical Center","ror":"https://ror.org/02v3txv81","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2803065977","https://openalex.org/I4210144745"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George A. Keepers","raw_affiliation_strings":["Psychiatry Service, Portland Veterans Affairs Medical Center, and the Department of Psychiatry, Oregon Health Sciences University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Service, Portland Veterans Affairs Medical Center, and the Department of Psychiatry, Oregon Health Sciences University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I2803065977"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105886857","display_name":"Daniel E. Casey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I2803065977","display_name":"Portland VA Medical Center","ror":"https://ror.org/02v3txv81","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2803065977","https://openalex.org/I4210144745"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel E. Casey","raw_affiliation_strings":["Psychiatry Service, Portland Veterans Affairs Medical Center, and the Department of Psychiatry, Oregon Health Sciences University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Service, Portland Veterans Affairs Medical Center, and the Department of Psychiatry, Oregon Health Sciences University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I2803065977"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":3.206,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.91095399,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":null,"biblio":{"volume":"4","issue":"4","first_page":"222","last_page":"225"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9678000211715698,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9678000211715698,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.01140000019222498,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/akathisia","display_name":"akathisia","score":0.8330000042915344},{"id":"https://openalex.org/keywords/drug-induced-parkinsonism","display_name":"drug-induced parkinsonism","score":0.9980000257492065},{"id":"https://openalex.org/keywords/neuroleptic-induced-parkinsonism","display_name":"neuroleptic-induced parkinsonism","score":0.7279999852180481},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.906000018119812},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.8500000238418579},{"id":"https://openalex.org/keywords/neuroleptic-dose","display_name":"neuroleptic dose","score":0.8190000057220459},{"id":"https://openalex.org/keywords/urinary-incontinence","display_name":"urinary incontinence","score":0.9520000219345093},{"id":"https://openalex.org/keywords/functional-status","display_name":"functional status","score":0.6380000114440918},{"id":"https://openalex.org/keywords/cognitive-status","display_name":"cognitive status","score":0.8510000109672546},{"id":"https://openalex.org/keywords/behavioral-problems","display_name":"behavioral problems","score":0.7620000243186951},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.9399999976158142}],"concepts":[{"id":"https://openalex.org/C2777393122","wikidata":"https://www.wikidata.org/wiki/Q416417","display_name":"Akathisia","level":4,"score":0.9501851797103882},{"id":"https://openalex.org/C2776525014","wikidata":"https://www.wikidata.org/wiki/Q1531991","display_name":"Parkinsonism","level":3,"score":0.8176904916763306},{"id":"https://openalex.org/C2780616385","wikidata":"https://www.wikidata.org/wiki/Q1385411","display_name":"Extrapyramidal symptoms","level":4,"score":0.6858230829238892},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5167869329452515},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.5041142702102661},{"id":"https://openalex.org/C2778261627","wikidata":"https://www.wikidata.org/wiki/Q2608695","display_name":"Movement disorders","level":3,"score":0.4287640154361725},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.42163902521133423},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.3721793591976166},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.35053104162216187},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3462103307247162},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33074578642845154},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.253581166267395},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.1155599057674408}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001480","descriptor_name":"Basal Ganglia Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D001480","descriptor_name":"Basal Ganglia Diseases","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D002746","descriptor_name":"Chlorpromazine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002746","descriptor_name":"Chlorpromazine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009460","descriptor_name":"Neurologic Examination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010302","descriptor_name":"Parkinson Disease, Secondary","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D010302","descriptor_name":"Parkinson Disease, Secondary","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D011595","descriptor_name":"Psychomotor Agitation","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D017109","descriptor_name":"Akathisia, Drug-Induced","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/089198879100400408","doi":"https://doi.org/10.1177/089198879100400408","is_oa":false,"landing_page_url":"https://doi.org/10.1177/089198879100400408","pdf_url":null,"source":{"id":"https://openalex.org/S182765863","display_name":"Journal of Geriatric Psychiatry and Neurology","issn_l":"0891-9887","issn":["0891-9887","1552-5708"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Geriatric Psychiatry and Neurology","raw_type":"journal-article"},{"id":"pmid:1686396","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1686396","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of geriatric psychiatry and neurology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8399999737739563}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W140075578","https://openalex.org/W177381987","https://openalex.org/W380863596","https://openalex.org/W1847168837","https://openalex.org/W1968860622","https://openalex.org/W1972843284","https://openalex.org/W1972904323","https://openalex.org/W1974611985","https://openalex.org/W1992083518","https://openalex.org/W1994131284","https://openalex.org/W1999343631","https://openalex.org/W2012656038","https://openalex.org/W2017221794","https://openalex.org/W2021873900","https://openalex.org/W2024796553","https://openalex.org/W2048154775","https://openalex.org/W2052624741","https://openalex.org/W2052692997","https://openalex.org/W2055537532","https://openalex.org/W2068154832","https://openalex.org/W2069837065","https://openalex.org/W2076498232","https://openalex.org/W2082664204","https://openalex.org/W2128529067","https://openalex.org/W2150290224","https://openalex.org/W2274971168","https://openalex.org/W2402057656","https://openalex.org/W2406331675","https://openalex.org/W2408384061","https://openalex.org/W2409028910","https://openalex.org/W2466726640","https://openalex.org/W2800075986","https://openalex.org/W2992201241","https://openalex.org/W4285719527","https://openalex.org/W4300718545","https://openalex.org/W4323254680"],"related_works":["https://openalex.org/W1993427365","https://openalex.org/W2047910917","https://openalex.org/W2023455708","https://openalex.org/W1986647444","https://openalex.org/W2144086396","https://openalex.org/W4301265897","https://openalex.org/W2163205616","https://openalex.org/W2044340148","https://openalex.org/W2055360307","https://openalex.org/W2418866086"],"abstract_inverted_index":{"The":[0],"incidence,":[1],"morbidity,":[2],"and":[3,14,47,50,59,71],"risk":[4],"factors":[5],"for":[6,38,43],"acute":[7,44,83],"extrapyramidal":[8],"syndromes":[9],"(EPS)":[10],"such":[11],"as":[12],"akathisia":[13],"drug-induced":[15],"parkinsonism":[16],"(DIP)":[17],"in":[18],"neuroleptic-treated":[19],"elders":[20],"have":[21],"not":[22],"been":[23],"systematically":[24],"explored.":[25],"This":[26],"study":[27],"presents":[28],"data":[29],"on":[30],"17":[31],"elderly":[32],"patients":[33],"who":[34],"were":[35],"prospectively":[36],"examined":[37],"up":[39],"to":[40,89],"4":[41],"weeks":[42],"EPS,":[45],"functional":[46,99],"cognitive":[48],"status,":[49],"behavioral":[51],"disturbances.":[52],"Seventy-one":[53],"percent":[54],"of":[55,64,76,79,82],"subjects":[56],"developed":[57,61],"DIP,":[58],"18%":[60],"akathisia.":[62],"Predictors":[63],"DIP":[65],"included":[66],"pre-neuroleptic":[67],"treatment":[68],"parkinsonian":[69],"signs":[70],"neuroleptic":[72],"dose,":[73],"despite":[74],"use":[75],"low":[77],"doses":[78],"neuroleptics.":[80],"Development":[81],"EPS":[84],"was":[85,95],"associated":[86],"with":[87],"failure":[88],"improve":[90],"behaviorally.":[91],"New-onset":[92],"urinary":[93],"incontinence":[94],"the":[96],"most":[97],"common":[98],"abnormality.":[100]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}